These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28969062)

  • 1. Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer.
    Wang L; Hu Y; Xiang X; Qu K; Teng Y
    Oncotarget; 2017 Sep; 8(38):64191-64202. PubMed ID: 28969062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.
    Zhu QN; Wang G; Guo Y; Peng Y; Zhang R; Deng JL; Li ZX; Zhu YS
    Oncotarget; 2017 Nov; 8(54):91990-92003. PubMed ID: 29190892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide profiling of long non-coding RNA expression patterns in anthracycline-resistant breast cancer cells.
    He DX; Zhang GY; Gu XT; Mao AQ; Lu CX; Jin J; Liu DQ; Ma X
    Int J Oncol; 2016 Oct; 49(4):1695-1703. PubMed ID: 27633960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer.
    Wang R; Du L; Yang X; Jiang X; Duan W; Yan S; Xie Y; Zhu Y; Wang Q; Wang L; Yang Y; Wang C
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2291-301. PubMed ID: 27591862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2.
    Guo L; Peng Y; Meng Y; Liu Y; Yang S; Jin H; Li Q
    Oncotarget; 2017 Sep; 8(40):68483-68492. PubMed ID: 28978132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis of mitochondria from human ovarian cancer cells and their paclitaxel-resistant sublines.
    Chen M; Huang H; He H; Ying W; Liu X; Dai Z; Yin J; Mao N; Qian X; Pan L
    Cancer Sci; 2015 Aug; 106(8):1075-83. PubMed ID: 26033570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells.
    Lee DH; Chung K; Song JA; Kim TH; Kang H; Huh JH; Jung SG; Ko JJ; An HJ
    J Proteome Res; 2010 Nov; 9(11):5668-76. PubMed ID: 20858016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long non-coding RNA signature for predicting survival in patients with colorectal cancer.
    Wang YL; Shao J; Wu X; Li T; Xu M; Shi D
    Oncotarget; 2018 Apr; 9(31):21687-21695. PubMed ID: 29774095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M; Liu B; Xiao J; Yang Y; Zhang Y
    Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
    Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer.
    Xue W; Li L; Tian X; Fan Z; Yue Y; Zhang C; Ding X; Song X; Ma B; Zhai Y; Lu J; Kan Q; Zhao J
    Oncotarget; 2017 Sep; 8(38):62868-62879. PubMed ID: 28968955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma.
    Feng L; Wang R; Lian M; Ma H; He N; Liu H; Wang H; Fang J
    PLoS One; 2016; 11(12):e0169232. PubMed ID: 28033431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer.
    Li Q; Zhang J; Zhou J; Yang B; Liu P; Cao L; Jing L; Liu H
    Oncol Lett; 2018 Jun; 15(6):8363-8370. PubMed ID: 29805570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.
    Sun Y; Zou X; He J; Mao Y
    Oncotarget; 2017 Aug; 8(32):52604-52613. PubMed ID: 28881755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.
    Zhong L; Lou G; Zhou X; Qin Y; Liu L; Jiang W
    Oncotarget; 2017 Sep; 8(40):67861-67870. PubMed ID: 28978079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.